MS Called Valeant "House of Cards" When Pitching Allergan – ValueWalk Premium
valeant pharmaceuticals

MS Called Valeant "House of Cards" When Pitching Allergan

Senior executives from Morgan Stanley (NYSE:MS), now said to be a key consultant to Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX), called Valeant a “house of cards,” in an e-mail to Allergan, Inc. (NYSE:AGN) management saying “your investors should not want to take their stock.”


Allergan has kicked up its pressure on the stock price of Valeant

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0